Cabaletta Bio (CABA) Operating Expenses (2018 - 2025)

Cabaletta Bio's Operating Expenses history runs 8 years deep, the most recent figure standing at $42.6 million for Q4 2025.

• In Q4 2025, Operating Expenses rose 26.12% year-over-year to $42.6 million; the TTM figure through Dec 2025 stood at $172.2 million (up 37.64% YoY), while the FY2025 annual figure was $172.2 million, up 37.64% from the prior year.
• Operating Expenses was $42.6 million for Q4 2025 at Cabaletta Bio, down from $46.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $46.6 million in Q3 2025 to a low of $9.7 million in Q1 2021.
• Historically, Operating Expenses has averaged $23.6 million across 5 years, with a median of $17.8 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses climbed 1.86% in 2022, then soared 90.55% in 2024.
• A 5-year view of Operating Expenses shows it stood at $13.9 million in 2021, then rose by 17.34% to $16.3 million in 2022, then soared by 41.98% to $23.1 million in 2023, then surged by 45.96% to $33.8 million in 2024, then advanced by 26.12% to $42.6 million in 2025.
• The last three Operating Expenses figures came in at $42.6 million (Q4 2025), $46.6 million (Q3 2025), and $45.9 million (Q2 2025), per Business Quant data.